GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (OTCPK:COPHF) » Definitions » ROA %

COPHF (Melodiol Global Health) ROA % : -186.34% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Melodiol Global Health ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Melodiol Global Health's annualized Net Income for the quarter that ended in Dec. 2023 was $-32.39 Mil. Melodiol Global Health's average Total Assets over the quarter that ended in Dec. 2023 was $17.38 Mil. Therefore, Melodiol Global Health's annualized ROA % for the quarter that ended in Dec. 2023 was -186.34%.

The historical rank and industry rank for Melodiol Global Health's ROA % or its related term are showing as below:

COPHF' s ROA % Range Over the Past 10 Years
Min: -183.94   Med: -120.27   Max: -66.99
Current: -175.15

During the past 8 years, Melodiol Global Health's highest ROA % was -66.99%. The lowest was -183.94%. And the median was -120.27%.

COPHF's ROA % is ranked worse than
96.16% of 1068 companies
in the Drug Manufacturers industry
Industry Median: 1.585 vs COPHF: -175.15

Melodiol Global Health ROA % Historical Data

The historical data trend for Melodiol Global Health's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health ROA % Chart

Melodiol Global Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial -65.66 -154.48 -121.47 -94.94 -182.95

Melodiol Global Health Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -74.59 -46.81 -146.80 -159.17 -186.34

Competitive Comparison of Melodiol Global Health's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Melodiol Global Health's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's ROA % distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's ROA % falls into.



Melodiol Global Health ROA % Calculation

Melodiol Global Health's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-35.104/( (25.629+12.747)/ 2 )
=-35.104/19.188
=-182.95 %

Melodiol Global Health's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-32.39/( (22.017+12.747)/ 2 )
=-32.39/17.382
=-186.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Melodiol Global Health  (OTCPK:COPHF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-32.39/17.382
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-32.39 / 15.966)*(15.966 / 17.382)
=Net Margin %*Asset Turnover
=-202.87 %*0.9185
=-186.34 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Melodiol Global Health ROA % Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Melodiol Global Health Business Description

Traded in Other Exchanges
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health Headlines

From GuruFocus

Sierra Sage Herbs Acquired By Creso Pharma

By PRNewswire PRNewswire 02-07-2022